Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in asymptomatic moderate-to-severe aortic stenosis
2011-000111-26Phase 2Unknown
- Sponsor
- Menarini Group
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ranolazine in aortic stenosis (AS), sponsored by Menarini Group. Primary endpoint: Peak diastolic strain rate. Status: unknown.
02
Drugs
ranolazine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2011-000111-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000111-26.